Sonodynamic therapy of cancer using novel sonosensitizers

Anticancer Research

Volumn 27, Issue 6 A, 2007, Pages 3673-3677

  Kuroki, Masahide ^a   Hachimine, Ken ^a   Abe, Hironori ^b   Shibaguchi, Hirotomo ^a   Kuroki, Motomu ^a   Maekawa, Shin Ichi ^a   Yanagisawa, Jun ^a   Kinugasa, Tetsushi ^a   Tanaka, Toshihiro ^a   Yamashita, Yuichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Tagawa Municipal Hospital   (Japan)

Author keywords

Cancer; Photodynamic therapy; Photosensitizer; Review; Sonodynamic therapy; Sonosensitizer

Indexed keywords

13,17 BIS (1 CARBOXYETHYL)8 [2(2,4 DICHLOROPHENYL HYDRAZANO)ETHYLIDENE] 3 ETHENYL 7 HYDROXY 2,7,12,18 TETRAMETHYLCHLORIN, DISODIUM SALT; 4 FORMYLOXIMETHYLIDENE 3 HYDROXY 2 VINYL DEUTERIO PORPHYNYL(IX) 6,7 DIASPARTIC ACID; 7,12 BIS (1 DECYLOXYETHYL) 2,18 BISPROPIONYLASPARTIC ACID 3,8,13,17 TETRAMETHYL PORPHYNATE GALLIUM (III)SALT; ATX 70; ATX S10; FREE RADICAL; GALLIUM; HEMATOPORPHYRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PORPHYRIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL DEATH; CELL GROWTH; COLON CARCINOMA; CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INHIBITION; DRUG MECHANISM; HUMAN; LOW LEVEL LASER THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL; ULTRASOUND;

ANIMALS; DIHEMATOPORPHYRIN ETHER; HEMATOPORPHYRINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; ULTRASONIC THERAPY; ULTRASONICS;

EID: 35348960904     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998.
2. Maunoury V, Mordon S, Bulois P, Mirabel X, Hecquet B and Mariette C: Photodynamic therapy for early esophageal cancer. Digest Liver Dis 37: 491-495, 2005.
3. Cuenca RE, Allison RR, Sibata C and Downie GH: Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 11: 322-327, 2004.
4. Jones BU, Helmy M, Brenner M, Serna DL, Williams J, Chen JC and Milliken JC: Photodynamic therapy for patients with advanced non-small-cell carcinoma of the lung. Clin Lung Cancer 3: 37-41, 2001.
5. Manyak MJ and Ogan K: Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium. J Endourol 17: 633-639, 2003.
6. Yamaguchi S, Tsuda H, Takemori M, Nakata S, Nishimura S, Kawamura N, Hanioka K, Inoue T and Nishimura R: Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 69: 110-116, 2005.
7. Umemura S, Yumita N and Nishigaki R: Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 84: 582-588, 1993.
8. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 80: 219-222, 1989.
9. Yumita N, Sasaki K, Umemura S, Yukawa A and Nishigaki R: Sonodynamically induced antitumor effect of gallium-porphyrin complex by focused ultrasound on experimental kidney tumor. Cancer Lett 112: 79-86, 1997.
10. Jin ZH, Miyoshi N, Ishiguro K, Umemura S, Kawabata K, Yumita N, Sakata I, Takaoka K, Udagawa T, Nakajima S et al: Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Dermatol 27: 294-306, 2000.
11. Yumita N, Nishigaki R, Sakata I, Nakajima S and Umemura S: Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2- vinyl-deuterio-porphynyl(IX)-6,7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91: 255-260, 2000.
12. Yumita N and Umemura S: Sonodynamic therapy with Photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitumoral efficacy of Photofrin II. Cancer Chemother Pharmacol 51: 174-178, 2003.
13. Yumita N, Nishigaki R and Umemura S: Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma. J Cancer Res Clin Oncol 126: 601-606, 2000.
14. Abe H, Kuroki M, Tachibana K, Li T, Awasthi A, Ueno A, Matsumoto H, Imakiire T, Yamauchi Y, Yamada H et al: Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 22: 1575-1580, 2002.
15. Nakajima S, Hayashi H, Omote Y, Yamazaki Y, Hirata S, Maeda T, Kubo Y, Takemura T, Kakiuchi Y, Shindo Y et al: The tumour-localizing properties of porphyrin derivatives. J Photochem Photobiol B 7: 189-198, 1990.
16. Maruyama M, Asano T, Uematsu T, Nakagohri T, Hasegawa M, Miyauchi H, Iwashita C and Isono K: Enhancement of the antitumor effect by combined use of high-energy shock waves and ATX-70. Jpn J Cancer Res 86: 800-801, 1995.
17. Miyoshi N, Misik V and Riesz P: Sonodynamic toxicity of gallium-porphyrin analogue ATX-70 in human leukemia cells. Radiat Res 148: 43-47, 1997.
18. Hachimine K, Shibaguchi H, Kuroki, M, Yamada H, Kinugasa T, Nakae Y, Asano R, Sakata I, Yamashita Y and Shirakusa T et al: Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity. Cancer Sci 98: 916-920, 2007.
19. Pervaiz S: Reactive oxygen-dependent production of novel photochemotherapeutic agents. FASEB J 15: 916-920, 2001.
20. Didenko YT, McNamara WB III and Suslick KS: Molecular emission from single-bubble sonoluminescence. Nature 407: 877-879, 2000.
21. Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11: 349-363, 2004.
22. Konno T, Watanabe J and Ishihara K: Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res 65A: 210-215, 2003.
23. Huang D, Okada K, Komori C, Itoi E and Suzuki T: Enhanced antitumor activity of ultrasonic irradiation in the presence of new quinolone antibiotics in vitro. Cancer Sci 95: 845-849, 2004.
24. Dellinger M: Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem Photobiol 64: 182-187, 1996.
25. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1: 1-21, 2002.
26. Kessel D and Luo Y: Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B 42: 89-95, 1998.
27. Noodt BB, Berg K, Stokke T, Peng Q and Nesland JM: Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer 79: 72-81, 1999.
28. Wyld L, Reed MWR and Brown NJ: Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 84: 1384-1386, 2001.
29. Krammer B: Vascular effects of photodynamic therapy. Anticancer Res 21: 4271-4277, 2001.
30. Dolmans DE, Kadambi A, Hill JS, Flores KR, Gerber JN, Walker JP, Borel Rinkes IH, Jain RK and Fukumura D: Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res 62: 2151-2156, 2002.
31. Korbelik M: Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 14: 329-334, 1996.
32. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT and Kuppen PJ: The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207: 105-113, 2003.